Besremi
| Besremi | |
|---|---|
| Term | Besremi |
| Short definition | Besremi - (pronounced) (bez-REH-mee) medicine used to treat adults with polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also being studied in the treatment of other conditions and some types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Besremi - (pronounced) (bez-REH-mee) medicine used to treat adults with polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also being studied in the treatment of other conditions and some types of cancer. Besremi is a form of recombinant interferon alfa-2b that's made in a laboratory and linked to a substance called PEG, which allows the drug to stay in the body longer. Besremi can reduce the number of red blood cells made in the bone marrow. It's a type of cytokine and a type of immunomodulating agent. Also called ropeginterferon alfa-2b
External links
- Medical encyclopedia article on Besremi
- Wikipedia's article - Besremi
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski